Discover
MRSN
Mersana Therapeutics, Inc.
29.08
2 x 20.63
2 x 36.80
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
29.36 +0.28 (0.96%)
| Ytd | 0.52% | |
| 1y | -14.47% |
28.78
day range
30.36
52 week range
| Open | 28.78 | Prev Close | 29.08 | Low | 28.78 | High | 30.36 | Mkt Cap | N/A |
| Vol | 704.86K | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -2.19 |
| Beta | 1.48 | Short Ratio | 6.45 | Inst. Own | 95.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 6.50 |
| Income Statement | |||
| Total Revenue | 11.01M | ||
| Revenues (USD) | 11.01M | ||
| Gross Profit | 11.01M | ||
| Operating Expenses | 18.68M | ||
| Research and Development Expense | 12.18M | ||
| Selling, General and Administrative Expense | 6.30M | ||
| Operating Income | -7.67M | ||
| Interest Expense | 394.00K | ||
| Net Income | -7.54M | ||
| Net Income Common Stock | -7.54M | ||
| Net Income Common Stock (USD) | -7.54M | ||
| Consolidated Income | -7.54M | ||
| Earnings per Basic Share | -1.51 | ||
| Earnings per Basic Share (USD) | -1.51 | ||
| Earnings per Diluted Share | -1.51 | ||
| Earning Before Interest & Taxes (EBIT) | -7.15M | ||
| Earning Before Interest & Taxes (USD) | -7.15M | ||
| Weighted Average Shares | 4.99M | ||
| Weighted Average Shares Diluted | 4.99M | ||
| Balance Sheet | |||
| Cash and Equivalents | 56.39M | ||
| Cash and Equivalents (USD) | 56.39M | ||
| Trade and Non-Trade Receivables | 168.00K | ||
| Current Assets | 59.99M | ||
| Property, Plant & Equipment Net | 2.20M | ||
| Total Assets | 62.69M | ||
| Debt Current | 2.29M | ||
| Total Debt | 2.29M | ||
| Current Liabilities | 43.27M | ||
| Total Liabilities | 122.22M | ||
| Accumulated Retained Earnings (Deficit) | -951.52M | ||
| Shareholders Equity | -59.54M | ||
| Shareholders Equity (USD) | -59.54M | ||
| Assets Non-Current | 2.70M | ||
| Total Debt (USD) | 2.29M | ||
| Deferred Revenue | 102.72M | ||
| Liabilities Non-Current | 78.95M | ||
| Trade and Non-Trade Payables | 2.39M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 942.00K | ||
| Net Cash Flow from Financing | -17.76M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -20.58M | ||
| Capital Expenditure | 372.00K | ||
| Issuance (Repayment) of Debt Securities | -17.76M | ||
| Net Cash Flow from Investing | 372.00K | ||
| Net Cash Flow from Operations | -3.19M | ||
| Share Based Compensation | 1.15M | ||